drugset / Trial / NCT00002451
Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
Treatment
Summary
The purpose of this study is to see if it is safe to give indinavir (IDV) and ritonavir (RTV) in combination with stavudine (d4T) and lamivudine (3TC) to HIV-positive patients who have never received anti-HIV therapy. This study will look at the effectiveness of this drug combination and side effects.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INDINAVIR ANHYDROUS | Other / unclassified | 1200 mg | — |
| Subject | Lamivudine | Other / unclassified | — | — |
| Subject | Ritonavir | Other / unclassified | 200 mg | — |
| Subject | Stavudine | Other / unclassified | — | — |